- Home
- SELF vs CTSO Comparison
SELF vs CTSO Comparison
Compare SELF & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SELF
- CTSO
- Stock Information
- Founded
- SELF 1983
- CTSO 1997
- Country
- SELF United States
- CTSO United States
- Employees
- SELF N/A
- CTSO N/A
- Industry
- SELF Real Estate Investment Trusts
- CTSO Medical/Dental Instruments
- Sector
- SELF Real Estate
- CTSO Health Care
- Exchange
- SELF Nasdaq
- CTSO Nasdaq
- Market Cap
- SELF 56.9M
- CTSO 52.6M
- IPO Year
- SELF N/A
- CTSO N/A
- Fundamental
- Price
- SELF $5.53
- CTSO $1.18
- Analyst Decision
- SELF
- CTSO Buy
- Analyst Count
- SELF 0
- CTSO 2
- Target Price
- SELF N/A
- CTSO $5.50
- AVG Volume (30 Days)
- SELF 24.3K
- CTSO 87.4K
- Earning Date
- SELF 08-08-2025
- CTSO 08-12-2025
- Dividend Yield
- SELF 5.25%
- CTSO N/A
- EPS Growth
- SELF 15.74
- CTSO N/A
- EPS
- SELF 0.22
- CTSO N/A
- Revenue
- SELF $12,622,544.00
- CTSO $35,332,238.00
- Revenue This Year
- SELF N/A
- CTSO $18.34
- Revenue Next Year
- SELF N/A
- CTSO $19.82
- P/E Ratio
- SELF $25.33
- CTSO N/A
- Revenue Growth
- SELF 3.58
- CTSO 15.37
- 52 Week Low
- SELF $4.60
- CTSO $0.70
- 52 Week High
- SELF $5.89
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- SELF 49.10
- CTSO 67.21
- Support Level
- SELF $5.61
- CTSO $1.03
- Resistance Level
- SELF $5.81
- CTSO $1.29
- Average True Range (ATR)
- SELF 0.13
- CTSO 0.09
- MACD
- SELF -0.04
- CTSO 0.02
- Stochastic Oscillator
- SELF 6.45
- CTSO 75.45
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to 13 self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.